Zhengye Biotechnology Holding Limited Impairment Charge on Reclassified Assets
Zhengye Biotechnology Holding Limited (ZYBT) reported Impairment Charge on Reclassified Assets of CNY 445.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2025-07-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentChargeOnReclassifiedAssets · last filed 2025-07-03
| Period end | Impairment Charge on Reclassified Assets 12 month |
|---|---|
| 2022-12-31 | 445.00K CNY 20-F · filed 2025-07-03 |